A Real-World, Multicenter, 6-Month Prospective Study in Greece of the

A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,Greece , ,Multivariable Linear Regression Analysis Of The Association ,Good Pharmacoepidemiology Practice ,International Society ,Institutional Review Boards ,Last Observation Carried Forward ,Disease Characteristics ,Anatomical Measures ,One Month ,Three Months Post Ranibizumab Treatment Onset ,Study Eyes ,Available Paired ,Six Months Post Ranibizumab Treatment Onset ,Treatment Characteristics ,Linear Regression Analysis ,Between Baseline ,Various Patient ,